TALLAN DEPRIEST: Open Payments
NPI 1548794399 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 35 payments from 11 companies in 2025. Trend: 2023 $912 · 2024 $325 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $272 |
| Lundbeck LLC | 5 | $98 |
| Braeburn Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Bausch Health US, LLC | 2 | $41 |
| Vertical Pharmaceuticals, LLC | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Almatica Pharma LLC | 1 | $18 |
Products named: VRAYLAR, REXULTI, BRIXADI, APLENZIN, Relexxii, Qelbree, FANAPT, COBENFY.
Industry payments across AZ — which companies pay providers there.
